| __timestamp | ADMA Biologics, Inc. | Alnylam Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 5915545 | 50561000 |
| Thursday, January 1, 2015 | 7177633 | 41097000 |
| Friday, January 1, 2016 | 10661037 | 47159000 |
| Sunday, January 1, 2017 | 22760560 | 89912000 |
| Monday, January 1, 2018 | 16985290 | 74908000 |
| Tuesday, January 1, 2019 | 29349083 | 219750000 |
| Wednesday, January 1, 2020 | 42219783 | 492853000 |
| Friday, January 1, 2021 | 80942625 | 844287000 |
| Saturday, January 1, 2022 | 154079692 | 1037418000 |
| Sunday, January 1, 2023 | 258214999 | 1828292000 |
| Monday, January 1, 2024 | 2248243000 |
In pursuit of knowledge
In the competitive landscape of biotechnology, Alnylam Pharmaceuticals and ADMA Biologics have been vying for dominance in yearly revenue. Since 2014, Alnylam has consistently outpaced ADMA, showcasing a remarkable growth trajectory. By 2023, Alnylam's revenue surged to nearly 1.83 billion, a staggering 3,500% increase from its 2014 figures. In contrast, ADMA Biologics, while showing impressive growth, reached 258 million in 2023, marking a 4,300% increase from 2014. This data highlights Alnylam's strategic advancements in RNA interference therapeutics, which have propelled its financial success. Meanwhile, ADMA's focus on immunoglobulin therapies has also yielded significant revenue growth, albeit at a smaller scale. As the biotech industry continues to evolve, these companies exemplify the dynamic nature of innovation-driven revenue growth.
Johnson & Johnson and ADMA Biologics, Inc.: A Comprehensive Revenue Analysis
Breaking Down Revenue Trends: Zoetis Inc. vs ADMA Biologics, Inc.
Who Generates More Revenue? Takeda Pharmaceutical Company Limited or Alnylam Pharmaceuticals, Inc.
Comparing Revenue Performance: Alnylam Pharmaceuticals, Inc. or Teva Pharmaceutical Industries Limited?
Annual Revenue Comparison: Alnylam Pharmaceuticals, Inc. vs Catalent, Inc.
Comparing Revenue Performance: Alnylam Pharmaceuticals, Inc. or Ionis Pharmaceuticals, Inc.?
Alnylam Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.: Annual Revenue Growth Compared
Comparing Revenue Performance: Alnylam Pharmaceuticals, Inc. or MiMedx Group, Inc.?
Who Generates More Revenue? Biogen Inc. or ADMA Biologics, Inc.
ADMA Biologics, Inc. and Amneal Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Who Generates More Revenue? ADMA Biologics, Inc. or ImmunityBio, Inc.
ADMA Biologics, Inc. vs Evotec SE: Examining Key Revenue Metrics